miR‐16‐5p Attenuated Airway Inflammation and Pulmonary Fibrosis of Asthma Rats by Regulating the TGF‐β1/Smad3 Signaling
Biotechnology and Applied Biochemistry · 2026
DOI: 10.1002/bab.70115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2026. Verfasst von Weiwei She und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin, China. Hauptthemen laut MEDLINE: Smad3 Protein, MicroRNAs, Transforming Growth Factor beta1, Asthma. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Natural Science Regional Fund Project.
Abstract (Originalsprache)
Bronchial asthma is a significant inflammatory disorder impacting the airways. While current therapeutic interventions manage these symptoms, they do not offer a cure for the condition. Emerging research indicates that specific microRNAs (miRNAs) are implicated in the pathogenesis of asthma and the associated airway remodeling. Notably, miR‐16‐5p has been identified as a regulator of TGF‐β1‐induced epithelial‐mesenchymal transition (EMT) in bronchial epithelial cells. This study investigates the influence of miR‐16‐5p on pulmonary function, inflammation, and fibrosis in asthma, focusing on its interaction with the TGF‐β1/Smad3 signaling pathway, using a rat model for experimental analysis. Male Sprague–Dawley rats were given ovalbumin (OVA) and aluminum hydroxide to create an asthma model. They were divided into six groups. miRNA treatments were delivered using PEG‐liposomes before each asthma challenge for 8 weeks. Asthma rats had lower levels of miR‐16‐5p. Elevating miR‐16‐5p levels improved breathing, reduced inflammation, and prevented lung damage. miR‐16‐5p regulated the TGF‐β1/Smad3 pathway by targeting Smad3, indicating its protective role against asthma. Increasing miR‐16‐5p levels can improve lung function, reduce inflammation, and prevent lung fibrosis in asthma rats by targeting Smad3 to block the TGF‐β1/Smad3 pathway. This finding suggests that miR‐16‐5p has translational potential as a novel therapeutic target for asthma treatment, which could lead to more effective strategies for asthma management in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin, China.
Förderung
- National Natural Science Regional Fund Project
Zitieren
APA
She, W., Sun, T., Long, C., Chen, M., Chen, X., Liao, Q., & Wang, M. (2026). miR‐16‐5p Attenuated Airway Inflammation and Pulmonary Fibrosis of Asthma Rats by Regulating the TGF‐β1/Smad3 Signaling. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.70115
Vancouver
She W, Sun T, Long C, Chen M, Chen X, Liao Q, et al. miR‐16‐5p Attenuated Airway Inflammation and Pulmonary Fibrosis of Asthma Rats by Regulating the TGF‐β1/Smad3 Signaling. Biotechnology and Applied Biochemistry. 2026. doi:10.1002/bab.70115
BibTeX
@article{She2026,
author = {She, Weiwei and Sun, Tianshou and Long, Chengfeng and Chen, Meiyu and Chen, Xu and Liao, Qinxue and Wang, Mingdong},
title = {miR‐16‐5p Attenuated Airway Inflammation and Pulmonary Fibrosis of Asthma Rats by Regulating the TGF‐β1/Smad3 Signaling},
journal = {Biotechnology and Applied Biochemistry},
year = {2026},
doi = {10.1002/bab.70115}
}
EUVIMED